FDA Approves Lucamzi (ranibizumab-blrz), a Biosimilar to Lucentis

Oct 31, 2026 - 11:00
 0  0
Solna, Sweden 27 October 2026 – Lucamzi™ (ranibizumab-blrz) biosimilar to Lucentis® has been approved by FDA in the US. Xbrane will finalize preparation for an upcoming launch of the product during 2027 together with its...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0